Sunday, May 3, 2026
wellness India Expo
Home Tags Biologics

Tag: Biologics

Riding on biologics wave, Biocon registers two fold growth during FY...

For the fiscal year ended March 2019, the Biocon's net profit rose over two-fold to Rs 905.3 crore as against Rs 372.4 crore for 2017-18. Company registered 64% growth in Q4 of FY19, earning 214 cr in net profits.................

ICT Mumbai set to host 5 day workshop on biosimilars characterization

Supported by the BIRAC, the workshop focused on learning of techniques for characterization of biosimilars/biologics will be held from December 11th to 15th at the Institute of Chemical Technology, Mumbai.............

USFDA accepts Mylan & Biocon’s proposed biosimilar Pegfilgrastim for review

The development marks the second successful biologics license application (BLA) for filing of the partnership in the United States of America...

Mylan & Biocon announce first joint USFDA submission for biosimilar, Trastuzumab

Besides being an important milestone of Biocon and Mylan's joint global biosimilars program, the first biosimilar trastuzumab if approved by the top regulator.....

Precision medicine can offer hope to rare disease patients

The rare diseases have not received the attention they deserved within the health policy initiatives in India, feels Prasanna Kumar B Shirol.....

Serum to invest whopping Rs 2k crore in new vaccine facility

Pune-based Serum Institute of India has started building a new manufacturing plant to supply adult vaccines to developed countries....

India gets new set of biosimilars guidelines, Industry welcomes move

While India has so far approved the manufacturing of 48 biosimilar products in the country, the biotechnology ...

Revised ‘India specific’ biosimilar guidelines expected soon

While the 'Biosimilar Guidelines' adopted in 2012 have been well appreciated, there was an overall sentiment ...

Mesa Consortium, a new human vaccine research hub

Human Vaccines Project has announced the launch of San Diego Research Hub in partnership with UC San Diego, J. Craig Venter Institute, La Jolla Institute and The Scripps Research Institute